Advertisement

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia

Bernd Boidol, Christoph Kornauth, Emiel van der Kouwe, Nicole Prutsch, Lukas Kazianka, Sinan Gültekin, Gregor Hoermann, Marius E. Mayerhoefer, Georg Hopfinger, Alexander Hauswirth, Michael Panny, Marie-Bernadette Aretin, Bernadette Hilgarth, Wolfgang R. Sperr, Peter Valent, Ingrid Simonitsch-Klupp, Richard Moriggl, Olaf Merkel, Lukas Kenner, Ulrich Jäger, Stefan Kubicek and Philipp B. Staber

Article Information

Citation 
vol. 130 no. 23 2499-2503
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted May 17, 2017
  • Accepted September 13, 2017
  • Published online December 7, 2017.

Article Versions


Contributors 
  • Bernd Boidol, 1Research Center for Molecular Medicine (CeMM) and 2Christian Doppler Laboratory for Chemical Epigenetics and Anti-Infectives, Austrian Academy of Sciences, Vienna, Austria;
  • Christoph Kornauth, 3Division of Hematology and Hemostaseology, Department of Internal Medicine I, 4Clinical Institute of Pathology,
  • Emiel van der Kouwe, 3Division of Hematology and Hemostaseology, Department of Internal Medicine I,
  • Nicole Prutsch, 4Clinical Institute of Pathology,
  • Lukas Kazianka, 3Division of Hematology and Hemostaseology, Department of Internal Medicine I,
  • Sinan Gültekin, 3Division of Hematology and Hemostaseology, Department of Internal Medicine I,
  • Gregor Hoermann, 5Department of Laboratory Medicine, and
  • Marius E. Mayerhoefer, 6Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria;
  • Georg Hopfinger, 3Division of Hematology and Hemostaseology, Department of Internal Medicine I,
  • Alexander Hauswirth, 3Division of Hematology and Hemostaseology, Department of Internal Medicine I,
  • Michael Panny, 73rd Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria;
  • Marie-Bernadette Aretin, 8Pharmacy Department, General Hospital and
  • Bernadette Hilgarth, 3Division of Hematology and Hemostaseology, Department of Internal Medicine I,
  • Wolfgang R. Sperr, 3Division of Hematology and Hemostaseology, Department of Internal Medicine I,
  • Peter Valent, 3Division of Hematology and Hemostaseology, Department of Internal Medicine I, 9Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria;
  • Ingrid Simonitsch-Klupp, 4Clinical Institute of Pathology,
  • Richard Moriggl, 10Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria; 11Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria; and 12Medical University of Vienna, Vienna, Austria
  • Olaf Merkel, 4Clinical Institute of Pathology,
  • Lukas Kenner, 4Clinical Institute of Pathology,
  • Ulrich Jäger, 3Division of Hematology and Hemostaseology, Department of Internal Medicine I,
  • Stefan Kubicek, 1Research Center for Molecular Medicine (CeMM) and 2Christian Doppler Laboratory for Chemical Epigenetics and Anti-Infectives, Austrian Academy of Sciences, Vienna, Austria;
  • Philipp B. Staber, 3Division of Hematology and Hemostaseology, Department of Internal Medicine I,

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output